Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - ISTA PHARMACEUTICALS INC | Financial_Report.xls |
| 10-Q - FORM 10-Q - ISTA PHARMACEUTICALS INC | d340348d10q.htm |
| EX-31.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 302 - ISTA PHARMACEUTICALS INC | d340348dex312.htm |
| EX-32.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 906 - ISTA PHARMACEUTICALS INC | d340348dex322.htm |
| EX-31.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 302 - ISTA PHARMACEUTICALS INC | d340348dex311.htm |
| EX-10.39 - FOURTH AMENDMENT TO BROMFENAC LICENSE AGREEMENT - ISTA PHARMACEUTICALS INC | d340348dex1039.htm |
EXHIBIT 32.1
CERTIFICATION
I, Vicente Anido, Jr., Ph.D., hereby certify pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, that the Quarterly Report of ISTA Pharmaceuticals, Inc. on Form 10-Q for the quarterly period ended March 31, 2012 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q for the period ended March 31, 2012 fairly presents in all material respects the financial condition and results of operations of ISTA Pharmaceuticals, Inc.
| Date: May 4, 2012 | ISTA Pharmaceuticals, Inc. | |
| /s/ Vicente Anido, Jr., Ph.D. | ||
| Vicente Anido, Jr., Ph.D. | ||
| President and Chief Executive Officer | ||
This certification accompanies the Quarterly Report pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934.